Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × retrovector encoding mutant anti-cyclin G1 × Clear all

NCT00504998 2011-06-10

Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms